Not for human consumption, veterinary use, or clinical administration. Sold exclusively to qualified laboratories and researchers for in-vitro study.
Semax is a synthetic heptapeptide analogue of the ACTH(4–7) fragment of adrenocorticotropic hormone, first developed at the Institute of Molecular Genetics in Moscow, and it has become a well-characterised subject in neuroscience research. Investigations have centred on its apparent neurotrophin-like behaviour — in particular its reported interaction with BDNF and TrkB receptor signalling, pathways studied in the context of neuronal survival and synaptic plasticity — as well as its influence on dopaminergic and serotonergic neurotransmission and on hypothalamic-pituitary-adrenal axis responses in pre-clinical models. Its ACTH-derived structure, paired with the absence of adrenocorticotropic activity, makes it a useful reference tool for laboratories studying neuropeptide pharmacology, cerebrovascular biology, and central-nervous-system peptide signalling. myPEPT supplies Semax at ≥99% verified purity with a batch Certificate of Analysis from independent lab testing, lyophilized and shipped across the EU in research-grade packaging. It is a research peptide for laboratory use only: it is not approved as a therapeutic or nootropic product for human use in most jurisdictions, is not for human consumption or injection, and should always be handled in accordance with your institution's neuroscience-compound protocols and applicable local regulations.
For research use only. This product is intended exclusively for in-vitro research and laboratory applications. Not approved for human or animal consumption, medical treatment, or therapeutic use.
For research use only. This product is intended exclusively for in-vitro research and laboratory applications. Not approved for human or animal consumption, medical treatment, or therapeutic use in the EU or US.

